Movement Alert｜Aehr Test Intraday Rise 8.16% in Regular Trading, Buy-the-Dip Call Follows Teradyne Competition Concerns

Market Focus10-19

On October 19, Aehr Test rose 8.16% in Regular Trading, trading at $65.39, with turnover of $85.60 million.

The move coincided with a fresh market view that the stock's earlier pullback after Teradyne's Titan HP launch had been overdone, with analysts arguing the decline created a buying opportunity.

Recent operating updates provide fundamental support. Over the past two months, the company disclosed a $22 million follow-on production order from its lead wafer-level AI processor customer, about $6 million in follow-on orders for AI chip testing equipment, and continued silicon photonics capacity-expansion orders. Those orders suggest demand remains intact for AI test and burn-in systems even as investors reassess competitive risks in semiconductor equipment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment